Spots Global Cancer Trial Database for autologous transplant
Every month we try and update this database with for autologous transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma | NCT02043860 | Multiple Myelom... | Total Marrow Ir... Autologous Tran... Melphalan Filgrastim (G-C... | 18 Years - 75 Years | University of Illinois at Chicago | |
| Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma | NCT01658904 | Multiple Myelom... Leukemia, Plasm... | Carfilzomib Melphalan Filgrastim | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma | NCT00024466 | Multiple Myelom... | GVAX Autologous tran... | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma | NCT01130194 | Follicular Lymp... | Combination of ... | 18 Years - 80 Years | St. Louis University | |
| The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD) | NCT00444912 | Non-Hodgkin Lym... Hodgkin Disease | G-CSF plus pler... G-CSF plus pler... rituximab | 18 Years - 70 Years | Sanofi | |
| Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia | NCT02842112 | Acute Myeloid L... | PBSC mobilizati... | 25 Years - 72 Years | Hospices Civils de Lyon | |
| Autologous Transplant in HIV Patients (BMT CTN 0803) | NCT01141712 | Lymphoma HIV | Autologous tran... BCNU Etoposide Cytarabine Melphalan | 15 Years - | Medical College of Wisconsin | |
| Use of Stem Cells in Lymphedema Post Mastectomy | NCT01112189 | Lymphedema Breast Cancer | Autologous tran... Compressed slee... | 18 Years - 75 Years | Hospital Universitario Dr. Jose E. Gonzalez | |
| Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT02353572 | Plasma Cell Mye... Plasmacytosis Recurrent Plasm... Smoldering Plas... | Melphalan Bortezomib Dexamethasone Autologous Tran... | 18 Years - 70 Years | University of Colorado, Denver | |
| Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT02353572 | Plasma Cell Mye... Plasmacytosis Recurrent Plasm... Smoldering Plas... | Melphalan Bortezomib Dexamethasone Autologous Tran... | 18 Years - 70 Years | University of Colorado, Denver | |
| Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen | NCT01048827 | Acute Myeloid L... | Busulfan | 18 Years - 69 Years | University of California, San Francisco | |
| Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Relapsed or Refractory Multiple Myeloma (BMT-03) | NCT02043847 | Multiple Myelom... Multiple Myelom... | Total Marrow Ir... Melphalan Filgrastim (G-C... Autologous tran... Total Marrow Ir... Melphalan Filgrastim (G-C... Autologous tran... Total Marrow Ir... Melphalan Filgrastim (G-C... Autologous tran... | 18 Years - 75 Years | University of Illinois at Chicago | |
| Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. | NCT05352789 | Haematological ... Bone Marrow Tra... Stem Cell Trans... Nutrition Aspec... Nutritional and... Exercise Interv... Prehabilitation | Non validated S... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) | NCT01109004 | Multiple Myelom... | Lenalidomide lenalidomide, b... Lenalidomide | - 70 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) | NCT01109004 | Multiple Myelom... | Lenalidomide lenalidomide, b... Lenalidomide | - 70 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) | NCT01109004 | Multiple Myelom... | Lenalidomide lenalidomide, b... Lenalidomide | - 70 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma | NCT01658904 | Multiple Myelom... Leukemia, Plasm... | Carfilzomib Melphalan Filgrastim | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma | NCT00670410 | Neuroblastoma | Related donor t... Cord blood tran... Busulfan Thymoglobulin Fludarabine | - 30 Years | Columbia University | |
| Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT02353572 | Plasma Cell Mye... Plasmacytosis Recurrent Plasm... Smoldering Plas... | Melphalan Bortezomib Dexamethasone Autologous Tran... | 18 Years - 70 Years | University of Colorado, Denver | |
| Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. | NCT05352789 | Haematological ... Bone Marrow Tra... Stem Cell Trans... Nutrition Aspec... Nutritional and... Exercise Interv... Prehabilitation | Non validated S... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) | NCT00096460 | Recurrent Grade... Recurrent Grade... Recurrent Grade... Follicular Lymp... | Cyclophosphamid... Filgrastim Chemotherapy or... Non-myeloablati... Allogeneic tran... Autologous tran... Rituximab maint... GVHD Prophylaxi... | - 75 Years | Medical College of Wisconsin | |
| Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT | NCT04685525 | Autologous Tran... Myeloma | Mycobiome Suppo... | 18 Years - | Case Comprehensive Cancer Center | |
| Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant | NCT01852591 | Multiple Myelom... | PCV 13 | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Use of Stem Cells in Lymphedema Post Mastectomy | NCT01112189 | Lymphedema Breast Cancer | Autologous tran... Compressed slee... | 18 Years - 75 Years | Hospital Universitario Dr. Jose E. Gonzalez | |
| Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT | NCT04685525 | Autologous Tran... Myeloma | Mycobiome Suppo... | 18 Years - | Case Comprehensive Cancer Center | |
| Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT04496011 | Fatigue Leukemia Lymphoma Multiple Myelom... Hematopoietic S... | Aerobic trainin... | 18 Years - 70 Years | Federal University of Health Science of Porto Alegre |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
